论文部分内容阅读
目的探讨曼月乐与新体380的避孕效果及不良反应发生率。方法选取我院2014年6月—2014年12月于计划生育门诊接收并要求进行人流后放置宫内节育的已婚妇女300例作为研究对象,按照对象节育要求,将其划分为观察组和对照组,观察组采用曼月乐节育方式避孕;对照组使用新体380避孕。随访一年,对两组对象的避孕效果和不良反应进行比较。结果曼月乐组闭经率为30.0%,出血率为2.21%,因病症取出率为2.21%,带器妊娠率为0;新体380出血率为7.49%,带器妊娠率和过敏率是0.82%,因病症取出率为8.32%,闭经率为0。曼月组出血率及因病症取出率明显低于新体380组,差异显著具有统计学意义,(P<0.05)。结论两组宫内节育器材均可获得良好的避孕效果,但曼月乐比新体380副作用低、满意度高、接受性高,是目前宫内避孕比较常用的节育方法,值得在临床上推广应用。
Objective To explore the effect of contraception and the incidence of adverse reactions between Mirena L and New Body 380. Methods Three hundred married women who received intrauterine contraception after family planning received the flow of their blood from June 2014 to December 2014 in our hospital were selected as research subjects. According to the requirements of birth control, they were divided into observation group and control group Group, the observation group using the method of birth control contraception Mirena; control group 380 newborn contraception. One year follow-up, the contraception and side effects of two groups of subjects were compared. Results The rate of menopause was 30.0%, the bleeding rate was 2.21%, the removal rate was 2.21%, the pregnancy rate was 0; the rate of newborn body hemorrhage was 7.49%, the pregnancy rate and allergy rate were 0.82 %, Due to illness removal rate of 8.32%, amenorrhea rate of 0. The rate of bleeding and the rate of removing due to illness in the Mirena group were significantly lower than that of the New-born 380 group (P <0.05). CONCLUSIONS: Good contraceptive efficacy is obtained in both intrauterine devices, but Mirenai has a lower side effect, higher satisfaction and higher acceptability than new body 380, which is the most commonly used birth control method for intrauterine contraception and is worthy of clinical promotion application.